With 160 deals in total so far, this year is on track to be a record year for Healthtech. Private Equity activity in the market, which has been steadily increasing over the last 10 years, made up 33% of all deals this quarter. 

Despite the increased number of deals in H1, disclosed M&A deal value accounted for $16.8B in total. 


At the the 2022 mid-year mark, Clearlake Capital and Constellation still lead the pack of Healthtech acquirers, scoring 7 acquisitions each, followed by 8 PE firms.